Paying retailers to reduce tobacco, alcohol and lottery marketing
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 19:17 ET (25-Oct-2026 23:17 GMT/UTC)
An initiative focused on partnering with retailers to decrease the influence of tobacco, alcohol and lottery marketing is showing promise and could present a more effective way to protect public health throughout the country, according to researchers at The Ohio State University.
The program, called Retailers Creating a Responsible Environment (Retailers CARE), launched in Montgomery County, Ohio, and may be the first effort in the nation to incentivize retailers to voluntarily reduce promotion of tobacco, alcohol and lottery products.
The new Institute for Applied Health Intelligence at UC San Diego will connect resources across six schools and UC San Diego health to generate next-generation solutions for pressing challenges in medicine.
Following the earlier deployment of MMAI Gym for Science for large language model (LLM) post-training, Insilico Medicine has expanded its generative AI capabilities through a strategic collaboration with Liquid AI, yielding a 2.6B parameter model optimized for retrosynthesis and a high-capacity 24B parameter model, both available for on-premise deployment and via the Microsoft Marketplace. To enable enterprise-grade automation, Insilico has unified its entire Pharma AI suite via the Model Context Protocol (MCP), allowing researchers to execute complex workflows directly within developer environments like Claude Code and Cursor. Concurrently, the company launched PandaClaw, an autonomous AI agent for multi-omics target discovery, alongside critical upgrades to its core suite: dynamic multibody simulation scaling in MDFlow, an expanded kinase profiling panel, advanced ionization states in generative chemistry, and enhanced MD simulations for metalloproteins.
A comprehensive review published in Nano Research reveals how mechanical forces—such as fluid shear, matrix stiffness, and cyclic strain—are essential for building realistic organoids and organ-on-a-chip models. The work bridges mechanobiology and microengineering, offering a roadmap for designing next-generation in vitro systems that truly mimic human physiology. These advances could revolutionize drug screening, disease modeling, and personalized medicine.
A Dartmouth study finds that AI may cost doctors time when corresponding with patients by making them spend more time editing AI-drafted responses than it would take to write them. The researchers analyzed 146,000 conversations between patients and their primary care physicians from the online portal of a large healthcare system and found that automated responses frequently introduced errors and extraneous details. But the study provides a framework for generating "good" AI responses that align with how clinicians communicate and shows that adapting AI to individual physicians can reduce editing by 26%. The study was presented at the 64th Annual Meeting of the Association for Computational Linguistics.
The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.
The initiative is part of the Korean government’s strategic efforts to establish a rapid-response vaccine development system capable of producing vaccine prototypes within 200 days of the emergence of a future pandemic. The Center will oversee the overall project, working in collaboration with biotechnology companies.
Hiroshima University researchers have demonstrated a proof of concept for the mass-production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique called Platinum TALEN.